April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
A Novel Method for Determining Choroidal Neovascularization Volumes in vivo
Author Affiliations & Notes
  • Thomas D. Olsen
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Ling Luo
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Bonnie Archer
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Kyle Jackman
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Ying Liu
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Krysten Zygmunt
    Scientific Computing and Imaging Institute,
    University of Utah, Salt Lake City, Utah
  • Ross Whitaker
    Scientific Computing and Imaging Institute,
    University of Utah, Salt Lake City, Utah
  • Balamurali K. Ambati
    Moran Eye Center,
    University of Utah, Salt Lake City, Utah
  • Footnotes
    Commercial Relationships  Thomas D. Olsen, None; Ling Luo, None; Bonnie Archer, None; Kyle Jackman, None; Ying Liu, None; Krysten Zygmunt, None; Ross Whitaker, None; Balamurali K. Ambati, None
  • Footnotes
    Support  NEI 5R01Ey01950
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1687. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thomas D. Olsen, Ling Luo, Bonnie Archer, Kyle Jackman, Ying Liu, Krysten Zygmunt, Ross Whitaker, Balamurali K. Ambati; A Novel Method for Determining Choroidal Neovascularization Volumes in vivo. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1687.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Choroidal neovascularization (CNV) volumes calculated by laser confocal microscopy combined with immunostaining is the most common method for CNV analysis. However, it only can be used in vitro and the CNV baseline cannot be evaluated. We developed new software, Seg3D, (University of Utah Center for Biomedical Computing) and determined if it can be used for in vivo CNV volume calculations.

Methods: : Laser induced CNV and aav.shRNA.sflt subretinal injection induced CNV were developed in C57BL6/j mice as CNV models. After 2 weeks-6 months, CNV was imaged by OCT & FA using Heidelberg Eye Explorer Spectralis HRA+OCT II and subsequently exported into the Seg3D program. The scaling factors for each dimension, x, y & z (µm/pixel), were recorded and the corneal curvature standard was changed from 7.7 to 1.75. Each lesion area, on 2 dimensional images, was outlined using the provided polyline tool in Seg3D. The total number of voxels inside the identified regions were counted and reported by Seg3D. The volume of each OCT image stack was calculated and then normalized by multiplying the number of voxels by the scaling factors for each dimension. Mice were euthanized and prepared for IHC staining immediately after Spectralis images were taken. The same CNV lesions were calculated using scanning laser confocal microscope after immunohistochemistry staining (Isolectin alexa fluor@546, invitrogen), as usual. The same z stack step size was used on both methods. Microsoft Excel was used to analyze the volume calculations of each method as well as the correlation statistic and average difference.

Results: : The CNV volume calculated using Seg3D (3.03x106µm3) was, on average, 2.5 times larger than the volumes (1.21 x106µm3) calculated using the laser confocal microscope (n=19, P=0.0006). The correlation statistical analysis showed 0.76 correlation between these two methods.

Conclusions: : Seg3D software is the singular method for CNV volume calculations in vivo to date. It can be used to analyze on the animal experiments with a normalized baseline requirement, as well as can be used to evaluate AMD in patients.

Keywords: choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • clinical research methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×